Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.91 USD | +4.72% | +0.80% | +22.48% |
Mar. 06 | Canaccord Genuity Adjusts Cara Therapeutics Price Target to $10 From $11, Maintains Buy Rating | MT |
Mar. 04 | Transcript : Cara Therapeutics, Inc., Q4 2023 Earnings Call, Mar 04, 2024 |
- Stock
- Equities
- Stock Cara Therapeutics, Inc. - Nasdaq
- News Cara Therapeutics, Inc.